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ABSTRACT 
Background: In age-related macular degeneration and inherited dystrophies, 
preservation of retinal ganglion cells has been demonstrated.  This finding has led to 
the development of various models of sub- or epi- retinal implant in order to restore 
vision.  The present study addresses the development of a polyimide subretinal 
electrode platform in the dystrophic P23H rat in vivo.   
Material and methods: We developed a technique for implanting a subretinal 
electrode into the subretinal space and stabilising the distal extremity of the cabling 
on the rat cranium in order to allow future electrical stimulations of the retina.   
Results: In vivo imaging of the retina with the scanning laser ophthalmoscope (SLO)  
demonstrated reasorbption of the surgically induced retinal detachment and the 
absence of major tissue reactions.  These in vivo observations were confirmed by 
retinal histology.  The extraocular fixation system on the rat cranium was effective in 
stabilising the distal connector for in vivo stimulation.   
Conclusion: This study demonstrates  that a retinal implant can be introduced into the 
subretinal space of a dystrophic rat with a stable external connection for repeatable 
electrical measurements and stimulation.  This in vivo model should therefore allow 
us to evaluate the safety and efficacy of electrical stimulations on dystrophic retina.
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INTRODUCTION 
 In retinal dystrophies and age-related macular degeneration (AMD), visual 
loss occurs as a consequence of photoreceptor degeneration.  As a result, a secondary 
process of partial trans-synaptic degeneration occurs affecting neurons distal to the 
degenerating photoreceptors.  There is histological evidence of some degree of 
ganglion cell sparing. [1] [2] [3] [4] [5]  Humayun and co-workers have reported that 
in vivo electrical stimulation of surviving retinal ganglion cells was able to generate 
phosphenes correlated spatially and temporally with the stimuli, demonstrating that 
these neurons were still able to convey visual information to the brain. [6] [7]  These 
findings support the assumption that electrical stimulation of surviving retinal cells by 
a retinal prosthesis might restore useful vision in ARMD or  retinal dystrophy.    
Strategies which have been proposed in order to trigger coordinated ganglion cell 
activity include subretinal stimulation, [8][9][10] epiretinal stimulation on the retinal 
inner limiting membrane [11] [12][13][14][15][16] or perineural stimulation around 
the optic nerve.[17][18]  
     The efficacy and safety of retinal implants have been investigated in 
different animal species in vivo.  A number of critical issues remain outstanding, such 
as surgical techniques, stimulation protocols, implant tolerance and biocompatibility.  
Subretinal prostheses have been implanted in living wild type pigs and cats 
where photoreceptors facing the implants eventually underwent degeneration 
associated  with  glial tissue formation.[19]  The retinal response to light was not 
however significantly altered by the presence of the implant as indicated by ERG 
recordings.   Retinal stimulation by the subretinal implant also elicited visual-evoked 
potentials consistent with an activation of retinal ganglion cells.[20][21][22] Self-
powered retinal implants have  been introduced into the subretinal space of RCS rats, 
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an animal model of retinitis pigmentosa, in order to demonstrate that the subretinal 
implant could slow the congenital retinal degeneration.[23]   This photoreceptor 
rescue was ascribed to a trophic effect of the implant on the retina.  A similar effect 
was seen in human experiments where visual performance improved at sites distant 
from the implant itself.[24]   
 The aim of this study was to design a surgical approach in vivo in the rat eye 
using a subretinal  implant activated by an external connector in order to evaluate the 
efficacy and safety of the stimuli on the retina.  The dystrophic P23H rat was selected 
for these experiments because this animal model of retinitis pigmentosa may provide 
a similar biological environment to patients with inherited photoreceptor 
degeneration.  The study shows that subretinal implants can be inserted for long term-
studies.     
  
MATERIALS AND METHODS 
Implants 
Initial experiments were conducted with inert polyimide (type PI2611) 
prototypes in order to test the technique and feasibility of the procedure.  In later 
experiments, we implanted devices with one or several platinum electrodes with a 
25µm radius.  These were produced at the Laboratory of Microsystems, EPFL, using 
a standard procedure. [25]  In brief, a layer of 11 µm polyimide (PI12611, HD 
Microsystems) was applied by spin-coating, and subsequently cured. A 200 nm-thick 
layer of platinum was deposited on the polyimide, using titanium as the adhesion 
layer.  The electrodes were shaped using dry etching.  A second layer of polyimide 
was then deposited, and the implant shape and electrode openings were engineered by 
dry etching.  The final total implant thickness was 22 µm.  The electrodes were then 
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soaked in 10% HCl and calibrated using Cole-Palmer® traceable test solutions.  To 
allow diffusion of nutrients and waste products, some implants were also supplied 
with through-holes with a diameter of 25 µm (Fig 1, 2a).      
 
Animals   
Animal experiments were conducted in accordance with the European 
Communities Council Directive (86/609/EEC) and the Association for Research in 
Vision and Ophthalmology (ARVO Statement on the Use of Animals in Ophthalmic 
and Vision Research).  Animals were maintained on a normal diet under a 12h 
light/dark cycle.  In all cases, surgery was performed in animals of at least 3 months.  
After pupil dilatation with a drop of tropicamide (2mg/0.4 ml, Ciba Vision 
Ophthalmics, Blagnac , France), P23H transgenic rats (line 1) were anaesthetized by 
intramuscular injection with a 4:1 mixture of ketamine-xylazine (ketamine 100mg/kg, 
xylazine 10 mg/kg) (Ketamine 500: Virbac, Carros, France; xylazine 2%: Rompun, 
Bayer Pharma, Puteaux, France).  One eye of each animal was implanted.  
 
Implantation techniques 
Once the animal was anesthetized, topical oxybuprocain chlorhydrate 1.6 
mg/0.4 ml (Novartis Pharma, 92500 Rueil-Malmaison, France) was instilled on the 
operated side. A superior conjunctival peritomy was performed.  A small radial 
sclerotomy was made 1.5 mm behind the limbus with a 25G needle.  Biolon

 (1% 
sodium hyaluronate, Bio-Technology General, Rehovot, Israel) was injected into the 
subretinal space through the sclerotomy in order to obtain a localized retinal 
detachment visible as a clear ‘flush-wave’ posterior to the injection.  The polyimide 
implant was gently inserted anterior to posterior into the subretinal space.  The 
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implant ‘tail’ was sewn to the sclera with 10-0 Nylon.  Visual control was obtained 
with indirect ophthalmoscopy.  
 
In vivo imaging 
Scanning laser ophthalmoscope (SLO) images were obtained in 4 rats 
(Heidelberg Engineering, Heidelberg, Germany).  Fluorescein angiograms were 
obtained by intraperitoneal injection of fluorescein (0.3ml of 4% fluorescein sodium, 
Fluka Chemie, Buchs, Switzerland).  Imaging was obtained without anesthetizing the 
animals. 
 
Impedance spectroscopy 
 Impedance spectra were measured with an LCR meter (Agilent 4284A, Palo 
Alto, USA) controlled by a proprietary Java-software. Measurements were taken 
between one stimulating electrode and the reference circular electrode. Each spectrum 
consisted of 60 points logarithmically spaced between 100Hz and 1MHz, with the 
sweep starting at the highest frequency. 
  
Histology  
At 9 weeks animals were anesthetized as described above to allow an intra-
cardiac perfusion of 4% paraformaldehyde in phosphate buffer 0.1M (pH= 7.4) at a 
10ml/min rate after clamping blood vessels irrigating the inferior part of the body.  
Once the eye was enucleated, the cornea and lens were removed by circumferential 
incision anterior to the ora serrata.  The implant tail was sectioned in order to maintain 
the implant head in the subretinal space.  Eye cups were incubated overnight at 4°C in 
phosphate buffer (0,1M ; pH=7,4) containing 4% paraformaldehyde and 2.5% 
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glutaraldehyde.  After several washes in phosphate buffer, the tissue was postfixed in 
osmium tetroxide 1% for 30 min at room temperature and rapidly rinsed in water.  
Finally, the tissue was dehydrated in alcohol and embedded in epoxy resin.  Semithin 
sections were obtained by ultramicrotome sectioning (Ultracut®, Leica) with a histo-
diamond (45°, 8 mm diatome), and stained with toluidine blue.  
 
RESULTS 
Implantation and imaging 
Figure 2 shows two different subretinal implants observed in vivo in the 
fundus.  The first implant prototypes were polyimide (type PI2611) bases only to 
assess the feasibility of the surgical procedure using various head shapes.  Implant 
head diameters > 1mm required large circumferential sclerotomies.  Larger prototypes 
were difficult to adapt to the tight curvature of the eye.  Prototypes with a smaller 
head diameter were also used but were abandoned as they did not provide sufficient 
space for multiple channel electrodes.  Symmetrical head designs were easier to insert 
under the retina and did not undergo lateral slippage during insertion as was the case 
for asymmetrical designs.  The most suitable prototype had a symmetrical head design 
with a 1000 µm diameter size and a connecting tail 250 µm large and 4 cm long (fig 
2b).  These prototypes were 22µm thick. 
  During this process, 26 rats underwent subretinal implantation in 5 operating 
sessions.  Postoperative examinations confirmed that the implants were in the 
subretinal space when retinal vessels were seen passing over the device.  Fourteen of 
26 implants were satisfactorily positioned in the subretinal space (54%); the success 
rate in the last 10 operated animals was 70%.  A number of post-implantation 
extrusions reduced the very high initial success rate for subretinal space positioning. 
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After up to 1.5 months, SLO imaging of the retinae showed no fibrous reaction 
in the vicinity of the implant and macroscopically normal tissue (Fig 2).  In one case, 
however, a hemorrhagic retinal detachment was observed at the level of the implant 
head.  
After establishing the most appropriate shape for the implant we then 
investigated how an external connector at the distal end of the implant could be made 
reliably accessible for repeated stimulations and recordings on the living animal. This 
external connector (6 male pins) connected to the implant tail was glued onto a 
plexiglass plate with araldite.  Implantation was performed under general anesthesia.  
A cutaneous incision on the cranial apex was performed and 2 small bore-screws 
inserted into the cranial apex as previously described for the stabilisation of 
intracerebral injection cannulae. [26]  A subcutaneous track was made between the 
lateral superior fornix of the implanted eye and the skin incision with a 16 G cannula.  
The implant head was ‘fed’ through this track distal to proximal before being inserted 
under the retina.  Once the intraocular procedure was completed, the proximal 
electrical connector plate was fixed with dental cement to the bore-screws in the skull 
The rapid curing of the paste provided a stable resting platform for the 
connector.  In order to safeguard it from post-surgical damage, the connector was 
protected in a casing made out of the proximal end of a screw-top Eppendorf tube.  To 
assess whether stimulations can be applied on non-anesthetized rats, sequential 
impedance measurements were achieved one week after implantation by applying a 
50 mV sine wave at different frequencies. In figure 3A, wires are seen leaving the 
implant connector on the non-anesthetized rat head and linking up with an LCR meter 
(seen in the background) via four BNC cables. Figure 3B illustrates the stability of the 
impedance measurements at 0, 15 and 60 minutes.     
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Retinal semi-thin sections confirmed that the retinal tissue was not greatly 
altered in the vicinity of the implant (Fig 4). In average, ganglion cells were observed 
at a distance of 149.9 µm (± 25.7 µm s.e.m., n=5) from the implant below the retina. 
  
CONCLUSION 
This study demonstrated that it was possible to implant platinum electrodes 
into the subretinal space of the P23H rat and to maintain a stable electrical connection 
between the electrodes and the extraocular connector, notwithstanding mechanical 
stress on the connector cable.  The implants remained in the subretinal space for up to 
1.5 months without histological evidence of glial scarring.  The few cases of 
proliferative vitreoretinopathy were attributed to the surgeon’s learning curve.  
  Subretinal implantation of various implant designs in mammals such as 
the cat, the rabbit , the non-dystrophic laboratory swine and the RCS rat have 
previously been reported [24][27].  In the latter, the subretinal implant was self-
powered and no external cabling was required [24]. Implantation in the rat, pig and 
cat has been obtained by elevating the retina with a subretinal fluid injection through a 
sclerotomy to create an iatrogenic retinal detachment [21][22] [24] [27] [28]. The 
implantation method is simple and reproducible.  Subretinal access is achieved by 
sclerotomy or sclerectomy without entering the vitreous cavity (ab externo) or by 
retinotomy or limbal sclerotomy using a vitrectomy approach (ab interno).  The latter 
techniques have been used in rabbits [9], minipigs [29] and cats [30].  Given the size 
of the rat globe and lens, this approach is not possible with current instrumentation.  
Zrenner and co-workers developed a custom-made implantation tool for 
multiphotodiode array (MPDA) implantation in the rat subretinal space [31].  
However, these MPDAs were stand-alone devices without the extraocular wire 
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connexion used in our experiments.   Subretinal implants have also been introduced in 
dystrophic RCS rats in order to demonstrate the neuroprotective effects of 
implantation, which were noted with both active and inactive implants [24].  These 
trophic effects, akin to those reported after phosphate buffer injection into the 
subretinal space [32] were ascribed to the effect of the surgery itself on the retina.    
RCS rats have defective phagocytosis of photoreceptor outer segments by the 
RPE.  This results from a recessively transmitted Mertk mutation which is solely 
expressed in the RPE.[33]  In this study we used P23H transgenic rats with the opsin 
mutation responsible for the most common form of autosomal dominant retinitis 
pigmentosa (adRP).  Line 1 rats, which were used in these experiments, have the 
highest level of transgene expression and the fastest rate of photoreceptor 
degeneration.  Histopathological and electrophysiological studies have shown broad 
similarities between human adRP P23H mutation and P23H rat retinal degeneration. 
[34]   
The difference in activation threshold between normal and dystrophic human 
retina that was reported with epiretinal implants further supports the use of a 
dystrophic mammal model to evaluate stimulating electrodes and protocols.  Although 
surgery in the rat is difficult given the small globe and large lens [35], dystrophic rats, 
with a life-span of up to 2 yrs, provide a unique model in which long term stimulation 
of the retina can be performed.  Electrophysiological measurements were recently 
achieved in vivo on rats just after implantation but were not performed following 
chronic stimulations. [36]  In further studies on P23H rats, which are readily available 
at a low cost relative to cats or pigs, we plan to investigate the safety and efficacy of 
long term retinal stimulation using the electrical connector attached to the animal’s 
head as shown in fig 2 as well as changes in electrical impedance over time using 
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electrical impedance spectroscopy, a technique with which it is possible to 
simultaneously characterize the conductivity of a tissue sample and the surface 
properties of the electrodes.[37]   The distance between implant and the retinal tissue 
as observed on histological sections already suggest that appropriate electrical 
stimulations of retinal cells should produce activation of visual centers.  
Various electrode sizes have been implanted into the subretinal space: 8 
platinum electrodes of 100 µm x 100µm  for direct electrical stimulation of the retina 
in the pig and rabbit [27],  an array of up to 5000 photodiodes with 20µm x 20 µm 
electrodes powered by incident light in the cat [28], a 2 mm diameter, 25µ thick chip 
with approximately 5000 independent microphotodiodes in human volunteers [23] 
 Our prototype has similar sized electrodes (25µm x25 µm), as we aim to 
produce a retinal implant with 100µm square pixel size stimuli.  Our group recently 
reported that a 3.5°x10° ‘window’ containing 286 pixels with a 100 µm square size 
was sufficient to allow reading of 4 letter words at 15° of eccentricity and that a 
window enlarged to 7°x10° (572 pixels) allowed fluent text reading [38] [39].  Based 
on these results, we designed stimulating test heads with 4 circular 25 µm radius 
electrodes  and a center-to- center spacing of 150 µm to allow for the generation of 
pixels >100 µm.  The 1000 µm diameter supporting base of our implant head could 
allow larger electrodes to be fitted if the current small-sized electrodes were unable to 
provide long term stimulations below the retinal safety threshold.  
In summary, we have implanted subretinal polyimide electrode platforms in 
the P23H rat, which provides an appropriate model for adRP in humans.  Although 
the surgical technique is difficult because of the very small globe size, subretinal 
implants in the  P23H rat should provide a valid model for assessing the electrical and 
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biological modalities of subretinal electrode stimulation with the aim of developing a 
retinal prosthesis in humans. 
 
FUNDING 
The present work was supported by : Swiss National Fund for Scientific Research 
(grants 3100-61956.00 and 3152-063915.00), Fondation pour les Aveugles (Geneva),  
Fédération des aveugles et Handicapés Visuels de France, Fondation des Gueules 
Cassées, INSERM, University Pierre and Marie Curie (Paris VI), Assistance 
Publique-Hôpitaux de Paris (AP-HP),  Fondation Ophtalmologique A. de Rothschild. 
 
ACKNOWLEDGMENTS 
The staff of the EPFL Center for MicroNanoTechnology is acknowledged for 
technical support in the fabrication of the electrodes. 
COMPETING INTERESTS: none declared 
 
 13
REFERENCES 
 
1 Stone JL, Barlow WE, Humayun MS et al.  Morphometric analysis of macular 
photoreceptors and ganglion cells in retinas with retinitis pigmentosa.  Arch 
Ophthalmol 1992;110:1634-1639 
2 Santos A, Humayun MS, de Juan MS et al. Preservation of the inner retina in 
retinitis pigmentosa. A morphometric analysis. Arch Ophtalmol 1997;115:511-
515 
3 Humayun MS, Prince M, de Juan EJ et al. Morphometric analysis of the 
extramacular retina from post-mortem eyes with with retinitis pigmentosa. Invest 
Ophthalmol Vis Sci 1996; 40:143-148 
4 Kim SY, Sadda S, Pearlman J et al. Morphometric analysis of the macula in eyes 
with disciform age-related macular degeneration.  Retina 2002; 22:471-7. 
5 Kim SY, Sadda S, Humayun MS et al.  Morphometric analysis of the macula in 
eyes with geographic atrophy due to age-related macular degeneration.  Retina 
2002; 22:464-70. 
6  Humayun MS, de Juan E Jr, Dagnelie G et al.  Visual perception elicited by 
electrical stimulation of retina in blind humans.  Arch Ophthalmol 1996; 114:40-
6. 
7  Humayun MS, de Juan E Jr, Weiland JD et al.  Pattern electrical stimulation of 
the human retina.  Vision Res 1999;39:2569-76. 
8  Chow AY, Chow VY.  Subretinal electrical stimulation of the rabbit retina. 
Neurosci Lett 1997; 225:13-6. 
 14
9  Zrenner E, Miliczek KD, Gabel VP et al. The development of subretinal 
microphotodiodes for replacement of degenerated photoreceptors. Ophthalmic 
Res 1997;29:269-80. 
10  Ziegler D, Linderholm P, Mazza M et al.  An active microphotodiode array of 
oscillating pixels for retinal stimulation.  Sens Actuators A Phys 2004;110: 11-17 
11  Kerdraon YA, Downie JA,Suaning GJ et al. Development and surgical 
implantation of a vision prosthesis model into the ovine eye. Clin Experiment 
Ophthalmol 2002;30:36-40 
12  Rizzo JF 3rd, Wyatt J, Loewenstein J et al. Methods and perceptual thresholds for 
short-term electrical stimulation of human retina with microelectrode arrays. Invest 
Ophthalmol Vis Sci 2003; 44:5355-61. 
13  Rizzo JF 3rd, Wyatt J, Loewenstein J et al. Perceptual efficacy of electrical 
stimulation of human retina with a microelectrode array during short-term surgical 
trials. Invest Ophthalmol Vis Sci 2003; 44:5362-9.  
14   Eckmiller R. Learning retina implants with epiretinal contacts. Ophthalmic Res 
1997; 29:281-9 
15   Humayun MS. Intraocular retinal prosthesis. Trans Am Ophthalmol Soc 
2001;99:271-300 
16  Humayun MS, Weiland JD, Fujii GY et al. Visual perception in a blind subject 
with a chronic microelectronic retinal prosthesis. Vision Res 2003; 43: 2573-81 
17  Veraart C, Raftopoulos C, Mortimer JT  et al. Visual sensations produced by optic 
nerve stimulation using an implanted self-sizing spiral cuff electrode. Brain Res 1998; 
813:181-6. 
18  Delbeke J, Oozeer M, Veraart C.  Position, size and luminosity of phosphenes 
generated by direct optic nerve stimulation. Vision Res 2003; 43:1091-102. 
 15
 19  Pardue MT, Stubbs EB Jr, Perlman J et al. Immunohistochemical studies of the 
retina following long-term implantation with subretinal microphotodiode arrays. Exp 
Eye Res 2001; 73:333-43. 
20  Pardue MT, Ball SL, Hetling Jr et al.  Visual evoked potentials to infrared 
stimulation in normal cats and rats.  Doc Ophthalmol 2001; S103(2):155-62.  
21  Schanze T, Sachs HG, Wiesenack C et al.  Implantation and testing of subretinal 
film electrodes in domestic pigs.   Exp Eye Res. 2005 Aug 24; [Epub ahead of print] 
22  Sachs HG, Schanze T, Wilms M.  Subretinal implantation and testing of 
polyimide film electrodes in cats.  Graefe’s Arch Clin Exp Ophthalmol 2005; 
243:464-468 
23  Pardue MT, Phillips MJ, Yin H et al.  Neuroprotective effect of subretinal 
implants in the RCS rat.  Invest Ophthalmol Vis Sci 2005;46:674-82 
24  Chow AY, Chow VY, Packo KH et al.  The artificial silicon retina microchip for 
the treatment of vision loss from retinitis pigmentosa.  Arch Ophthalmol 
2004;122:460-9. 
 23  Pardue MT, Phillips MJ, Yin H et al.  Neuroprotective effect of subretinal 
implants in the RCS rat.  Invest Ophthalmol Vis Sci 2005; 46:674-82 
25  Metz S, Bertsch A, Bertrand D et al.  Flexible polyimide probes with 
microelectrodes and embedded microfluidic channels for simultaneous drug delivery 
and multi-channel monitoring of bioelectric activity.  Biosens Bioelectron 
2004;19:1309-1318    
26  Banisadr G, Queraud-Lesaux F, Boutterin MC et al.  Distribution, cellular 
localization and functional role of CCR2 chemokine receptors in adult rat brain.  J 
Neurochem 2002;81:257-69. 
27  Schwahn HN, Gekeler F, Kohler K et al.  Studies on the feasibility of a subretinal 
 16
visual prosthesis: data from Yucatan micropig and rabbit.  Graefes Arch Clin Exp 
Ophthalmol 2001;239:961-7. 
28  Chow AY, Pardue MT, Chow VY et al.  Implantation of silicon chip 
microphotodiode arrays into the cat subretinal space. IEEE Trans Neural Syst Rehabil 
Eng 2001;9:86-95. 
29  Hämmerle H, Kobuch K, Kohler K et al.  Biostability of microphotodiode arrays 
for subretinal implantation.  Biomaterials 2002; 23:797-804 
30  Chow AY, Pardue MT, Perlman JI et al.  Subretinal implantation of 
semiconductor-based photodiodes: durability of novel implant designs. J Rehabil Res 
Dev 2002; 39:312-322  
31  Zrenner E, Stett A, Weiss S et al. Can subretinal microphotodiodes successfully 
replace degenerated photoreceptors? Vision Res 1999;39:2555-67. 
32  Frasson M, Picaud S, Leveillard T et al.  Glial cell line-derived neurotrophic 
factor induces histologic and functional protection of rod photoreceptors in the rd/rd 
mouse.  Invest Ophthalmol Vis Sci 1999; 40:2724-34 
33  D'Cruz PM, Yasumura D et al.  Mutation of the receptor tyrosine kinase gene 
Mertk in the retinal dystrophic RCS rat.  Hum Mol Genet 2000;9:645-51 
34  Machida S, Kondo M, Jamison JA et al.  P23H rhodopsin transgenic rat: 
correlation of retinal function with histopathology.  Invest Ophthalmol Vis Sci 
2000;41:3200-9 
35 Zrenner E.  The subretinal implant: can microphotodiode arrays replace 
degenerated retinal photoreceptors to restore vision?  Ophthalmologica. 2002;216: 
S1:8-20; discussion 52-3 
 17
 36  Baig-Silva MS, Hathcock CD, Hetling JR.  A preparation for studying electrical 
stimulation of the retina in vivo in rat. J Neural Eng 2005;2:S29-38.  Epub 2005 Feb 
22 
37 Grimnes S, Martinsen  0.  Bioimpedance and Bioelectricity Basics,   
Cornwall, Academic Press  2000:3 
38  Sommerhalder J, Oueghlani E, Bagnoud M et al.  Simulation of artificial vision:   
I.  Eccentric reading of isolated words, and perceptual learning.  Vision Res. 
2003;43:269-83.  
39  Sommerhalder J, Rappaz B, de Haller R et al.  Simulation of artificial vision: II.  
Eccentric reading of full-page text and the learning of this task. Vision Res 
2004;44:1693-706  
  
 
 
 
 
 
 
 
 18
LEGENDS 
 
Figure 1: Different retinal implant designs which were implanted a) a 3 mm wide 
device with 4 central stimulating electrodes and a reference elctrode on the 4 sides  b) 
a 1 mm device with four stimulating electrodes and a large circular reference 
electrode. Some of these were equipped with 25 µm holes for increased diffusion; c) a 
250 µm asymmetric implant with only one central electrode. 
 
Figure 2: In vivo SLO images of retinal implants in dystrophic rats. A) Rat fundus   
showing a 250 µm implant head in the subretinal space. B) Fluorescein angiography 
obtained 1.5 months after the surgery and showing retinal blood vessels passing above 
the subretinal 1000 µm implant head  
 
Figure 3: In vivo stimulation for implant impedance measurements. A) Non-
anesthetized animal connected to an LCR meter. The Eppendorf cap protecting the 
external implant connector on the skull is visible. This connector is wired to an LCR 
meter seen in the background through a switch board (not shown) and four BNC 
cables. B) Impedance spectra. Impedance measurement obtained at different 
frequencies with a 50mV sine wave stimulation. The measurements were repeated at 
the beginning of the experiment (0min, dark  15min (red) and 60 min (blue)).   
 
Figure 4: Retinal semithin section showing the subretinal implant. Note that retinal 
cells are in apposition to the retinal implant.  The scale bar represents 100 µm. 
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